Real-time enrollment status for this bladder cancer clinical trial
Current Status
Active, Not Recruiting
Checked: March 2, 2026 at 10:33 AM UTC
| NCT Number | NCT06211764 |
| Recruiting Status | Active, Not Recruiting |
| Condition | Bladder Cancer |
| Phase | Clinical Trial |
| Target Enrollment | 250 participants |
| Active Locations | 29 sites in the US |
| Sponsor | Janssen Research & Development, LLC |
| Last Updated on CT.gov | January 16, 2026 (Jan 16, 2026) |
As of March 2, 2026: Clinical trial NCT06211764 is currently active_not_recruiting participants. This clinical trial study for bladder cancer is not currently accepting new participants at 29 locations across the United States. The study is sponsored by Janssen Research & Development, LLC. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT06211764 is currently active_not_recruiting. The study may resume recruiting in the future.
This trial is recruiting at 29 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06211764 was last updated Jan 16, 2026 (January 16, 2026). HelloStudys verifies this status automatically.